NCCN-protocol care · 45-minute detailed consultations · ArogyaSri, CGHS & cashless insurance accepted · Free second opinion
1800 202 8726
Genetics Explained · Reviewed by CION Oncologists · NABH Accredited

Genetic Testing for Lynch Syndrome — What Actually Happens

Genetic testing sounds more dramatic than it is. In practice it is a conversation, a blood sample, and a wait — and for most women who reach this stage, a reassuring result. What matters is understanding the sequence, because the tumour test and the blood test answer different questions and are frequently confused. The tumour test asks what is happening in the cancer. The blood test asks what you were born with. Only the second can diagnose Lynch syndrome, only it has implications for your children, and it is arranged through counselling rather than ordered like a routine investigation.

  • Two different tests — one looks at the tumour, one looks at you — they answer different questions
  • Counselling comes first — the conversation before the blood test, not after the result
  • It is a blood or saliva sample — the test itself is unremarkable; the preparation is the substance
  • Three possible answers — positive, negative, or uncertain — and the third is common
4.8 · 1,000+ Google reviews · 15,000+ patients treated
Genetic Counselling Available

Considering Genetic Testing?

₹950   Today: FREE  ·  Consultation with a woman doctor on request

Counselling before testing, so you know what results would mean
Family implications explained rather than left to you
Confidential. No commitment to proceed.
or
Call 18002028726
17+
Cancer Specialists
on Panel
35+
Centres
Across India
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

The Process, in Order

Five stages. Most women reading this are already past the first.

  • Tumour testing. Done routinely on every endometrial cancer. Mismatch repair immunohistochemistry, with MLH1 methylation testing added if MLH1 protein is missing. This is a screen, not a diagnosis. See MMR and MSI testing.
  • Referral for genetic counselling. Triggered by the tumour result, by your age at diagnosis, or by your family history. This is where the decision about testing is actually made. See what genetic counselling involves.
  • The counselling appointment. Family history taken properly from both sides, the possible results explained, the implications for relatives discussed, and consent taken. Longer than a normal appointment, and deliberately so.
  • The sample. Blood in most cases, sometimes saliva. Unremarkable in itself — the substance of this process is either side of it.
  • The result appointment. Results are given in person rather than by post or phone, because all three possible outcomes need explaining and two of them lead to decisions.

Timescales vary considerably between centres and depend on whether the analysis is done in-house or sent to a reference laboratory. Several weeks is typical; ask at your counselling appointment so you are not waiting without a reference point.

Did You Know? If an affected relative is still living, testing usually starts with her rather than with you — and this is counter-intuitive enough that families often resist it. The reason is straightforward. A negative result in someone who has never had cancer is difficult to interpret, because it does not distinguish between a family that carries no variant and a family whose variant simply has not been found yet. A result in a relative who has had the cancer is far more informative: if a variant is identified in her, everyone else can be tested for that specific change, and a negative result then genuinely means negative. Sources: NCCN Clinical Practice Guidelines in Oncology — Genetic/Familial High-Risk Assessment: Colorectal, Endometrial and Gastric; ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma; American College of Medical Genetics and Genomics standards for interpretation of sequence variants.
12+ Centres in Hyderabad · Pick yours

CION cancer care is closer than you think.

We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.

Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.

Help me pick the right centre

The Three Possible Results

Women prepare themselves for two. The third catches people off guard, and it is common enough that it should not.

ResultWhat it means and what follows
Pathogenic variant found Lynch syndrome is confirmed. You would be offered colonoscopy from a younger age, awareness of other associated cancers, and discussion of risk-reducing surgery once childbearing is complete. Your first-degree relatives can be tested for that specific variant. This is a clear result with a clear plan attached.
No variant detected Reassuring, and worth understanding precisely. It means no pathogenic change was found in the genes tested. It does not entirely exclude an inherited cause, since a variant could lie somewhere not covered by the test, and if the family history is strongly suggestive that may still influence what surveillance is recommended.
Variant of uncertain significance A change was found whose meaning is not yet known — not clearly harmful, not clearly harmless. It is not a diagnosis and should not be treated as one. Management continues to be based on your personal and family history, and relatives are not tested for it. Classifications are periodically revisited as evidence accumulates, and many are eventually reclassified as harmless.

The uncertain result deserves emphasis, because it is where most avoidable distress occurs. A variant of uncertain significance is common, it is not a Lynch diagnosis, and it does not mean you have something that has not been named yet. Genetics services expect these results and know how to handle them — which is precisely why testing is done through a service rather than ordered in isolation.

Been Referred for Testing and Unsure What It Involves?

A conversation, a blood sample, and a result explained in person. We will go through what each outcome would mean before anything is decided.

or
Call 18002028726
Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

The Testing Is Simple. The Conversation Around It Is the Point.

Which is why counselling comes first — so you understand the possible answers before you have one.

Practical Questions Worth Asking

These come up in most counselling appointments and are easier asked than assumed.

“How long will the result take?”

Turnaround varies considerably depending on whether the analysis is performed in-house or sent to a reference laboratory, and arrangements differ between centres. Several weeks is typical. Ask specifically at the counselling appointment, so that you have a reference point rather than waiting indefinitely and assuming something has gone wrong.

“What will it cost, and is any of it covered?”

Genetic testing carries a real cost and coverage varies by scheme and by whether testing is being done for diagnostic purposes in someone already affected. Ask about the total cost including counselling, and about what your insurance or state scheme would meet, before proceeding rather than partway through. See genetic testing cost.

“Who else needs to know?”

A positive result has implications for relatives, and how that information reaches them is a genuine question rather than an afterthought. Genetics services are experienced at supporting this and can provide a family letter explaining the finding and what relatives should do. You are not expected to hold the conversation alone or unaided.

“Do I have to be tested?”

No. Declining is a legitimate choice and counselling is designed to help you reach a decision rather than to steer you to one. Some women decide the information would not change what they do; others want it precisely because it would. It is also a decision you can defer — the option remains open, and the tumour material stays available.

Want to Talk It Through Before Deciding?

Whether testing is appropriate in your case, what each result would mean, and what it would ask of your family. The opinion is free.

or
Call 18002028726

Testing Relatives Is a Different and Simpler Process

Once a variant has been identified in one family member, testing everyone else becomes much more straightforward. The hard part of genetic testing is finding a variant in the first place; looking for one you already know about is comparatively simple.

  • The test is targeted. Rather than examining whole genes for any possible change, the laboratory looks for one specific known variant. Faster, cheaper and definitive.
  • The result is a clear yes or no. No uncertain results, because the change being looked for has already been classified. This is the one situation in this field where the answer is genuinely binary.
  • A negative result means population risk. A relative who does not carry the family variant is not at increased risk and needs no additional surveillance — which is a substantial relief and a real benefit of the whole process.
  • A positive result opens surveillance before any cancer exists. This is where the greatest benefit of the entire pathway lies: identifying someone healthy, and preventing a cancer rather than treating one. See Lynch syndrome and your family.

For what surveillance then involves, see surveillance with Lynch syndrome and risk-reducing hysterectomy.

Why Testing Belongs Inside a Service

Because a third of the possible answers is ambiguous, and that answer needs someone who deals with it routinely.

Lynch counselling built in

Where testing suggests an inherited cause, genetic counselling is arranged rather than mentioned, and the implications for your family are explained to you.

MMR / MSI testing as standard

Every endometrial tumour is tested for mismatch repair status. It guides treatment choice and flags the women who should be offered Lynch syndrome counselling.

45-minute consultations

Long enough to go through the scan, the report and the options properly — with a woman doctor available on request at every location.

Tumour board for every diagnosis

Surgical, medical and radiation oncology review each case together before a plan is proposed, rather than one specialist deciding alone.

Costs explained before you commit

A written estimate before treatment starts, with the Aarogyasri and NTR Vaidya Seva routes explained where you are eligible for them.

Decisions for healing, not billing

No unnecessary tests, and no treatment proposed that the tumour board has not agreed is the right one for your stage and grade.

Take The Next Step

Most Women Who Reach Testing Get a Reassuring Result

And the ones who do not get a plan, and the chance to protect their relatives.

Real Stories. Real Voices.

15,000+ patients chose CION. Hear from them directly.

These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.

4.8★800+ Google reviews
50+video testimonials
15,000+patients treated

Successful Chemotherapy Done by Dr. C Raghavendra Reddy

Watch video →

Surgery, Chemo & Radiation Done by Dr. Imaduddin, Dr. Vinay, Dr. Owais, Dr. Kirti

Watch video →

Successful Radical Thymectomy Done by Dr. Mohammed Imaduddin & Dr. Vinay Mamidala

Watch video →

Successful Surgery Done by Dr. Rajender Byshetty

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Radiation Done by Dr. Owais Mohammed & Dr. Kirti Ranjan Mohanty

Watch video →

Successful Breast Cancer Surgery Done by Dr. Imaduddin Mohammed & Dr. Vinay Mamidala

Watch video →

Successful Chemotherapy Done by Dr. Bharati Devi Gorantla

Watch video →

Successful Chemo & Surgery Done by Dr. Owais Mohammed & Dr. Imaduddin Mohammed

Watch video →

Successful Chemotherapy Done by Dr. Gundu Naresh

Watch video →

Successful Bone Marrow Transplantation - Neuroblastoma

Watch video →

Successful Surgery & Chemo - Carcinoma of Caecum

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Surgery by Dr. Mohammed Imaduddin

Watch video →

Successful Bone Marrow Transplantation

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Buccal Mucosa Surgery

Watch video →

Successful Complex Surgery Mandibulectomy Reconstruction

Watch video →
Common questions

Genetic Testing for Lynch Syndrome — Frequently Asked Questions

What is the difference between the tumour test and the genetic test?

They answer different questions and are frequently confused. Mismatch repair testing is performed on the tumour tissue and asks whether the DNA repair system is working within that cancer. It is done on every endometrial cancer, and an abnormal result is common — most often because the tumour has silenced one of its own repair genes, an acquired change with no implications for your family. Germline genetic testing is performed on a blood or saliva sample and asks what you were born with, examining the mismatch repair genes in your normal cells. Only this second test can diagnose Lynch syndrome, and only it has implications for your children and relatives.

What does the testing actually involve?

Less than most people expect. There is a genetic counselling appointment first, which is longer than a normal consultation: your family history is taken properly from both sides, the possible results and their implications are explained, and consent is discussed. Then a sample is taken — blood in most cases, sometimes saliva. Then a wait, typically several weeks, though this varies depending on whether the analysis is done in-house or sent to a reference laboratory. Then a result appointment, given in person rather than by phone or post, because all three possible outcomes need explaining and two of them lead to decisions.

What is a "variant of uncertain significance"?

It means a change was found in one of the genes tested, but its clinical meaning is not yet established — it is not clearly harmful and not clearly harmless. This is a common outcome and it is the one women are least prepared for. Importantly, it is not a diagnosis of Lynch syndrome and should not be treated as one: management continues to be based on your personal and family history, and relatives are not tested for it. Classifications are periodically revisited as more evidence accumulates across laboratories worldwide, and a substantial proportion of these variants are eventually reclassified as harmless.

Why would my relative be tested before me?

Because a result in someone who has had the cancer is far more informative. If a relative who developed endometrial or bowel cancer is still living, testing her first makes sense: if a pathogenic variant is found in her, everyone else in the family can then be tested for that specific change, and a negative result genuinely means negative. By contrast, testing someone who has never had cancer first can produce a negative result that is hard to interpret, because it does not distinguish between a family carrying no variant and a family whose variant simply has not been found. Families often find this counter-intuitive, but it is the more informative order.

Do I have to have the test?

No. Declining is a legitimate choice, and genetic counselling exists to help you reach a decision rather than to steer you towards one. Some women conclude the information would not change what they do; others want it precisely because it would — bowel screening from a younger age is the largest practical benefit, and the implications for relatives are the other major consideration. It is also a decision you can defer rather than refuse permanently: the option remains open, and the tumour material stays available. If you are unsure, that is a reason to attend the counselling appointment rather than to avoid it.

Medical disclaimer: This page describes the process of genetic testing for Lynch syndrome in general terms and is reviewed by a CION oncologist, following current NCCN guidance on genetic and familial high-risk assessment. Arrangements, turnaround times and costs vary between centres and testing may be performed in-house or sent to a reference laboratory. It is general health information rather than advice about your own case; decisions about testing should be made through genetic counselling.

Explore more

Explore All Endometrial Cancer Topics

Browse our complete library of endometrial (uterine) cancer guides — covering symptoms, risk factors, Lynch syndrome, diagnosis, precancer, types and staging, treatment, fertility, survival, survivorship and cost in Hyderabad.

Call now Book free consultation